HER-2 NEGATIVE BREAST CANCER
Clinical trials for HER-2 NEGATIVE BREAST CANCER explained in plain language.
Never miss a new study
Get alerted when new HER-2 NEGATIVE BREAST CANCER trials appear
Sign up with your email to follow new studies for HER-2 NEGATIVE BREAST CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for advanced breast cancer: drug duo aims to slow disease
Disease control Recruiting nowThis study tests a combination of two drugs, utidelone and bevacizumab, in people with advanced HER-2 negative breast cancer who have already tried at least two other treatments. The goal is to see if the combo can delay cancer growth or shrink tumors. About 79 women aged 18-70 w…
Matched conditions: HER-2 NEGATIVE BREAST CANCER
Phase: PHASE2 • Sponsor: Henan Cancer Hospital • Aim: Disease control
Last updated May 01, 2026 15:59 UTC
-
New drug combo offers hope for Tough-to-Treat breast cancer
Disease control Recruiting nowThis study tests a combination of two drugs, eribulin and anlotinib, for people with HER2-negative breast cancer that has spread or come back. Participants have already tried other treatments like antibody-drug conjugates, but their cancer continued to grow. The goal is to see if…
Matched conditions: HER-2 NEGATIVE BREAST CANCER
Phase: PHASE2 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Apr 30, 2026 15:52 UTC